A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

Neurology
S L RogersL T Friedhoff

Abstract

The efficacy and safety of donepezil as a treatment for patients with mild to moderate Alzheimer's disease (AD) was investigated in a multicenter, double-blind study. Patients were randomly assigned to treatment with placebo (n = 162), 5 mg/d donepezil (n = 154), or 10 mg/d donepezil (n = 157) for 24 weeks followed by a 6-week, single-blind placebo washout. The primary efficacy measures were the cognitive portion of the Alzheimer's Disease Assessment Scale (ADAS-cog) and the Clinician's Interview Based Assessment of Change-Plus (CIBIC plus), with the Mini-Mental State Examination (MMSE), Clinical Dementia Rating Scale-Sum of the Boxes (CDR-SB), and patient rated Quality of Life (QoL) used as secondary measures. Cognitive function, as measured by the ADAS-cog, was significantly improved in the 5- and 10-mg/d donepezil groups as compared with the placebo group at weeks 12, 18, and 24. Clinician's global ratings on the CIBIC plus also improved in both the 5- and 10-mg/d donepezil groups relative to placebo. At the end of the 6-week placebo washout phase, ADAS-cog scores and CIBIC plus ratings were not significantly different for the three groups. Significant treatment benefits were also observed consistently in both the 5- and 10-...Continue Reading

Citations

Jun 9, 2000·Statistics in Medicine·R G ThomasL Thal
Jan 14, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·H H FernandezS Beason-Hazen
Aug 7, 2002·Pharmazie in unserer Zeit·Walter E Müller
Oct 23, 2002·Journal of Neuroscience Research·Cheol Hyoung ParkYoo-Hun Suh
Jul 13, 2001·Annals of Nuclear Medicine·H Matsuda
Aug 23, 2006·Annals of Nuclear Medicine·Yo UshuijimaTsunehiko Nishimura
May 11, 2004·Aging Clinical and Experimental Research·Claudio PedoneRoberto Bernabei
Jul 4, 2007·Aging Clinical and Experimental Research·Luca RozziniAlessandro Padovani
Nov 17, 2007·Aging Clinical and Experimental Research·Giovanni B FrisoniOrazio Zanetti
Jan 31, 2009·Aging Clinical and Experimental Research·Luca RozziniAlessandro Padovani
May 25, 2005·European Journal of Clinical Pharmacology·Roberto RaschettiNicola Vanacore
Feb 28, 2013·European Journal of Clinical Pharmacology·Linda BrewerDavid Williams
Apr 4, 2007·European Archives of Psychiatry and Clinical Neuroscience·Stefan J TeipelMichael Happich
Feb 19, 2009·European Archives of Psychiatry and Clinical Neuroscience·Breno Satler DinizOrestes Vicente Forlenza
Nov 9, 2007·Journal of Neurology·I NozakiM Yamada
Sep 9, 2006·Radiation Medicine·Hiroshi Matsuda
Oct 13, 2006·Current Treatment Options in Oncology·Jerome M ButlerEdward G Shaw
Mar 20, 2002·Current Neurology and Neuroscience Reports·D Knopman
Aug 25, 2006·Current Neurology and Neuroscience Reports·David S Knopman
Dec 21, 2000·Current Psychiatry Reports·B M McLendonP M Doraiswamy
Jul 10, 2012·Current Psychiatry Reports·Yonas E Geda
Oct 26, 2013·Computational Statistics & Data Analysis·Chengjie XiongJohn C Morris
Apr 1, 2003·Current Therapeutic Research, Clinical and Experimental·George T Grossberg
Apr 20, 2000·European Journal of Pharmacology·A Maelicke, E X Albuquerque
Dec 14, 1999·European Journal of Pharmacology·C BejarM Weinstock
Nov 6, 2002·Journal of the Neurological Sciences·L FrölichF M Berger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.